BioPharma

21 October, 2026 | Wednesday | News

PharmaEssentia Accelerates Global Expansion with US and Japan Drug Approvals and US$46 Million Manufacturing Investment

PharmaEssentia Corporation (TWSE: 6446), a Taiwan-based biopharmaceutical company, is expanding its global presence through new drug approvals, clinical trials and overseas investments, as it seeks to bri...

Lab

20 October, 2026 | Tuesday | News

Cotecna Accelerates India Life Sciences Expansion With Acquisition of Hyderabad-Based Energon Labs

Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services,  announced the acquisition of Energon Labs, a cGMP-compliant, USFDA-inspected, ISO 9001:2015 and ISO 17025:2017 certifie...

BioTech

22 October, 2026 | Thursday | News

Metabolon Launches AI-Enabled Splash & Ripple to Accelerate Metabolomics-Driven Drug Discovery

New bioinformatics application combines curated metabolite-protein knowledge, advanced network algorithms, interactive exploration, and optional AI interpretation to generate clearer mechanistic hypotheses Met...

Contract Services

14 October, 2026 | Wednesday | News

360biolabs Expands Australian Footprint with New Bioanalytical Laboratory in Sydney

  The new 360biolabs facility in North Ryde is strategically located within one of Sydney’s vibrant science and medtech hubs, Macquarie Park Innovation District alongside a growing community of inno...

Consumer Health

15 October, 2026 | Thursday | News

Roche Secures Global Rights to Rona Therapeutics’ RNAi Obesity Candidate in Deal Worth Up to $1.16 Billion

- Rona Therapeutics announced it has granted Roche an exclusive worldwide license for Rona's investigational RNAi candidate targeting activin receptor-like kinase 7 (ALK7) utilizing the company's proprietary ex...

Medtech

22 October, 2026 | Thursday | News

Insilico Medicine Hits First AI-Driven Oncology Milestone in $888 Million Servier Collaboration

Two programs under the multi-year R&D collaboration have initiated and completed target nomination since its early 2026 announcement. Insilico reached the first R&D milestone using its proprietary Ph...

Cell & Gene

16 October, 2026 | Friday | News

NueCell Bio Joins CIRM Partnership to Accelerate Cell and Gene Therapies from Discovery to GMP Readiness

NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness, announced it has joined the Industry Resource Partnership (IRP) Program of the Cali...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close